Literature DB >> 26724323

Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study.

Éric Toussirot1, Antoine Martin2, Martin Soubrier3, Serge Redeker4, Alexis Régent5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26724323     DOI： 10.3899/jrheum.150599

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

Review 1.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 2.  Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

3.  Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.

Authors:  Valérie Devauchelle-Pensec; Jean Marie Berthelot; Divi Cornec; Yves Renaudineau; Thierry Marhadour; Sandrine Jousse-Joulin; Solène Querellou; Florent Garrigues; Michel De Bandt; Maelenn Gouillou; Alain Saraux
Journal:  Ann Rheum Dis       Date:  2016-02-29       Impact factor: 19.103

4.  Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?

Authors:  Éric Toussirot; Alexis Régent; Valérie Devauchelle-Pensec; Alain Saraux; Xavier Puéchal
Journal:  RMD Open       Date:  2016-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.